Analytical and clinical evaluations of Snibe Maglumi<sup>®</sup> S100B assay
The Maglumi<sup>®</sup> S100B assay can be used in the management of mTBI patients to exclude unnecessary CT scans. Further studies are needed to validate a clinical decision threshold for CT scan decisions.
Authors
- Damien Bouvier (ORCID: https://orcid.org/0000-0002-2707-4320)
- L Picard
- Vincent Sapin (ORCID: https://orcid.org/0000-0002-7452-315X)
- Samy Kahouadji (ORCID: https://orcid.org/0000-0002-5918-1315)
- Valentin Bailly Defrance
- Bruno Pereira (ORCID: https://orcid.org/0000-0003-4955-1770)
- Jean-Baptiste Bouillon-Minois
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- University of Clermont Auvergne (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Clermont Université (FR)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1515/cclm-2024-1508
- Primary Topic
- Traumatic Brain Injury and Neurovascular Disturbances
- Type
- article
- Field-Weighted Citation Impact
- 0.00